Exosome Diagnostics Inc - Product Pipeline Analysis, 2019 Update

Exosome Diagnostics Inc - Product Pipeline Analysis, 2019 Update

Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Table of Contents
Exosome Diagnostics Inc Company Overview
Exosome Diagnostics Inc Company Snapshot
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc – Pipeline Analysis Overview
Exosome Diagnostics Inc - Key Facts
Exosome Diagnostics Inc - Major Products and Services
Exosome Diagnostics Inc Pipeline Products by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Pipeline Products Overview
Biofluid Nucleic Acid Kit - Alzheimer's Disease
Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview
Biofluid Nucleic Acid Kit - Cardiovascular Disease
Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview
Biofluid Nucleic Acid Kit - Chronic Kidney Disease
Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview
Biofluid Nucleic Acid Kit - Parkinson's Disease
Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview
Biofluid-Based Molecular Diagnostic Test - Brain Cancer
Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview
BIONIC Liquid Biopsy - Bladder Cancer
BIONIC Liquid Biopsy - Bladder Cancer Product Overview
Diagnostic Test - Neurodegenerative Diseases
Diagnostic Test - Neurodegenerative Diseases Product Overview
ExoDx Lung(EGFR)
ExoDx Lung(EGFR) Product Overview
ExoDx Prostate(IntelliScore) - IVD Version
ExoDx Prostate(IntelliScore) - IVD Version Product Overview
ExoDx Prostate(IntelliScore) - IVD Version Clinical Trial
ExoDx Prostate(IntelliScore) - LDT
ExoDx Prostate(IntelliScore) - LDT Product Overview
Next-Generation Solid Tumor Mutation Panel
Next-Generation Solid Tumor Mutation Panel Product Overview
Shahky
Shahky Product Overview
Exosome Diagnostics Inc - Key Competitors
Exosome Diagnostics Inc - Key Employees
Exosome Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exosome Diagnostics Inc, Recent Developments
Jun 17, 2019: FDA grants breakthrough device designation to Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test
Jun 13, 2019: Bio-Techne receives approval to offer The ExoDx Prostate Intelliscore (EPI) test in New York State
Sep 18, 2018: Bio-Techne announces publication of data demonstrating additional clinical validation of its EPI Test in European Urology Journal
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test
May 08, 2018: Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate(IntelliScore) (EPI) Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc Pipeline Products by Equipment Type
Exosome Diagnostics Inc Pipeline Products by Indication
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc, Key Facts
Exosome Diagnostics Inc, Major Products and Services
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Ongoing Clinical Trials Summary
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
BIONIC Liquid Biopsy - Bladder Cancer - Product Status
BIONIC Liquid Biopsy - Bladder Cancer - Product Description
Diagnostic Test - Neurodegenerative Diseases - Product Status
Diagnostic Test - Neurodegenerative Diseases - Product Description
ExoDx Lung(EGFR) - Product Status
ExoDx Lung(EGFR) - Product Description
ExoDx Prostate(IntelliScore) - IVD Version - Product Status
ExoDx Prostate(IntelliScore) - IVD Version - Product Description
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study including Impact on Decision-making and Health Economics
ExoDx Prostate(IntelliScore) - LDT - Product Status
ExoDx Prostate(IntelliScore) - LDT - Product Description
Next-Generation Solid Tumor Mutation Panel - Product Status
Next-Generation Solid Tumor Mutation Panel - Product Description
Shahky - Product Status
Shahky - Product Description
Exosome Diagnostics Inc, Key Employees
Exosome Diagnostics Inc, Subsidiaries
Glossary
List of Figures
Exosome Diagnostics Inc Pipeline Products by Equipment Type
Exosome Diagnostics Inc Pipeline Products by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook